Gestational diabetes mellitus in a cohort of HIV-1 infected women

被引:34
作者
Gonzalez-Tome, M. I. [1 ]
Amador, J. T. Ramos [2 ]
Guillen, S. [2 ]
Solis, I. [3 ]
Fernandez-Ibieta, M. [2 ]
Munoz, E. [4 ]
Almeda, J. [5 ]
Rojano, X. [5 ]
Rojo, P. [1 ]
Nieto, O.
机构
[1] Hosp 12 Octubre, Dept Immunodeficiencies, E-28041 Madrid, Spain
[2] Hosp Getafe, Dept Pediat, Madrid, Spain
[3] Hosp Getafe, Dept Gynecol, Madrid, Spain
[4] Hosp 12 Octubre, Dept Gynecol, E-28041 Madrid, Spain
[5] CEESCAT Ctr Epidemiol Studies HIV AIDS Catalonia, Barcelona, Spain
关键词
antiretroviral therapy; gestational diabetes mellitus; HIV infection; pregnancy; protease inhibitor;
D O I
10.1111/j.1468-1293.2008.00639.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives We undertook a prospective study to estimate the prevalence of gestational diabetes mellitus (GDM) and associated risk factors in a cohort of 669 HIV-1 infected women. Methods The O'Sullivan and glucose tolerance tests were performed during regular visits of 609 mothers. Results The median age of the cohort was 30.7 years (range 16-44), with most women having had heterosexual contact (67%). The majority were in Centers for Disease Control (CDC) category A (71%) and 53% exhibited hepatitis C co-infection. Median viral load and CD4 count at third trimester were 545 cells/mu L (range 139-1690 cells/mu L) and 1.9 log (range 1.7-5.4), respectively. Seventy-four per cent of the patients were treated with highly active antiretroviral therapy (HAART), of whom 41% received a protease inhibitor (PI). An above-average prevalence of 7% [95% confidence interval (CI) 5.2-9.5] for positive GDM diagnosis was found. Risk factors associated with GDM in univariate analysis included older age, hepatitis C co-infection, stavudine and PI exposure. However, only older age [adjusted odds ratio (AOR) 1.09, 95% CI 1-1.1] and PI exposure (AOR 2.4, 95% CI 1-5.3) remained as independent risk factors for GDM development in multivariate analysis. Conclusions In our cohort, the prevalence of GDM appears to be increased, with older age and PI exposure contributing as significant independent risk factors.
引用
收藏
页码:868 / 874
页数:7
相关论文
共 35 条
[1]  
*AM COLL OBST GYN, 1994, OBSTET GYNECOL, V98, P525
[2]   Insulin resistance complicating pregnancy in a human immunodeficiency virus-infected patient treated with protease inhibitors and corticosteroids [J].
Aschkenazi, S ;
Rochelson, B ;
Bernasko, J ;
Kaplan, J .
OBSTETRICS AND GYNECOLOGY, 2003, 102 (05) :1210-1212
[3]   Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals [J].
Brambilla, AM ;
Novati, R ;
Calori, G ;
Meneghini, E ;
Vacchini, D ;
Luzi, L ;
Castagna, A ;
Lazzarin, A .
AIDS, 2003, 17 (13) :1993-1995
[4]   Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the multicenter AIDS cohort study [J].
Brown, TT ;
Li, XH ;
Cole, SR ;
Kingsley, LA ;
Palella, FJ ;
Riddler, SA ;
Chmiel, JS ;
Visscher, BR ;
Margolick, JB ;
Dobs, AS .
AIDS, 2005, 19 (13) :1375-1383
[5]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[6]   Protease inhibitors and decreased birth weight in HIV-infected pregnant women with impaired glucose tolerance [J].
Chmait R. ;
Franklin P. ;
Spector S.A. ;
Hull A.D. .
Journal of Perinatology, 2002, 22 (5) :370-373
[7]  
COVADONGA M, 2007, ACTA OBSTET GYNECOL, V86, P409
[8]   Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women [J].
Danoff, A ;
Shi, QH ;
Justman, J ;
Mulligan, K ;
Hessol, N ;
Robison, E ;
Lu, DL ;
Williams, T ;
Wichienkuer, P ;
Anastos, K .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (01) :55-62
[9]  
DIEZ JJ, 1989, MED CLIN-BARCELONA, V93, P41
[10]  
Dubé MP, 2001, J ACQ IMMUN DEF SYND, V27, P506